Clinical Research Center of Cape Cod

Clinical Research Center of Cape Cod (CRCCC) is a premier clinical research site based in Hyannis, Massachusetts, specializing in Phase II-IV clinical trials for the pharmaceutical and biotechnology industries. Established in 1998, the center has built a reputation for excellence in Central Nervous System (CNS) research, focusing on indications such as depression, Alzheimer's disease, and anxiety disorders. In 2021, CRCCC was acquired by CenExel, integrating it into a nationwide network of high-performing research facilities. The center offers comprehensive services including patient recruitment, study coordination, and specialized medical evaluations. It serves as a critical partner for sponsors seeking high-quality data and efficient trial execution in psychiatric and neurological medicine.